Company Quick10K Filing
R1 RCM
10-Q 2021-03-31 Filed 2021-05-04
10-K 2020-12-31 Filed 2021-02-18
10-Q 2020-09-30 Filed 2020-11-03
10-Q 2020-06-30 Filed 2020-08-05
10-Q 2020-03-31 Filed 2020-05-05
10-K 2019-12-31 Filed 2020-02-20
10-Q 2019-09-30 Filed 2019-11-05
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-22
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-09
10-Q 2017-09-30 Filed 2017-10-31
10-Q 2017-06-30 Filed 2017-08-02
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-10
10-Q 2015-09-30 Filed 2015-11-09
10-Q 2015-03-31 Filed 2015-07-07
10-Q 2014-12-31 Filed 2015-08-05
10-K 2014-12-31 Filed 2015-06-23
10-Q 2014-09-30 Filed 2015-06-23
10-Q 2014-06-30 Filed 2015-06-23
10-Q 2014-03-31 Filed 2015-06-23
10-K 2013-12-31 Filed 2014-12-30
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-18
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
8-K 2020-11-05
8-K 2020-11-03
8-K 2020-08-04
8-K 2020-07-20
8-K 2020-07-14
8-K 2020-06-03
8-K 2020-05-27
8-K 2020-05-05
8-K 2020-04-29
8-K 2020-04-01
8-K 2020-03-20
8-K 2020-02-20
8-K 2020-01-09
8-K 2019-12-27
8-K 2019-11-05
8-K 2019-09-20
8-K 2019-08-07
8-K 2019-08-06
8-K 2019-06-26
8-K 2019-06-13
8-K 2019-05-09
8-K 2019-04-16
8-K 2019-04-10
8-K 2019-03-07
8-K 2019-02-22
8-K 2019-01-07
8-K 2018-11-07
8-K 2018-10-01
8-K 2018-09-20
8-K 2018-08-09
8-K 2018-07-24
8-K 2018-06-24
8-K 2018-05-31
8-K 2018-05-30
8-K 2018-05-16
8-K 2018-05-09
8-K 2018-05-08
8-K 2018-04-26
8-K 2018-04-24
8-K 2018-04-17
8-K 2018-04-02
8-K 2018-03-26
8-K 2018-03-20
8-K 2018-03-09
8-K 2018-02-23
8-K 2018-01-24
8-K 2018-01-08

R1 RCM Financials

RCM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302012-03-312012-06-302012-09-302013-12-312014-03-312014-06-302014-09-302014-12-312014-12-312015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1501822142011962292081541941451221321381032812222021811431321431651704255651188156
Accounts Receivable921071111251372514139435510979497888414042414340
Inventory
PP&E2424273036434344454659496466686567727897101103108156169177194213204
Assets313348408423429510508463489446464447491460526493450415351342354336345753768808908913901
Accounts Payable30272336434665121066524482777515810141825
Long-Term Debt359360379359382368
Liabilities121139153162171596639604616589654617714674388387308256848195113126531554593691690663
Stockholders' Equity192208255261258-86-130-141-127-142-190-170-224-213-21-58-25-129181753325241064415
Income Statement ($MM)2011-06-302011-09-302012-03-312012-06-302012-09-302013-12-312014-03-312014-06-302014-09-302014-12-312014-12-312015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue18421925423722384135991472211166835291261188799123140147208250263276295301
Cost of Revenue1371702092311774548454443424539454547628196112127139190219237246242
Gross Profit4749454546-3211454-21-31-2930307-36785663111391831394959
R&D
SG&A131517211817191716211721151825161614121515172230222628
Tax551-14-30-105-16-19-226111-292414000013110-119
Net Income971-136-55-1710-18-26-30-335167-413713-8-7-4-40-23-3-13-60-59
Cash Flow ($MM)2011-06-302011-09-302012-03-312012-06-302012-09-302013-12-312014-03-312014-06-302014-09-302014-12-312014-12-312015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3114-816-20-1426-301-54-17-18-2851925-10-111571-27-1
Cash Investing-2-4-6-9-1-0-2-3-5-3-10-4-2-4-3-2-9-14-7-4-3-477-2-15-18-11
Cash Financing280-11050-0178-2-0-0-2-1-1018361-0-47-12